Measurement of Distinct Biological Pools of Hydrogen Sulfide in Women With Cardiovascular Disease

Sponsor
Louisiana State University Health Sciences Center Shreveport (Other)
Overall Status
Completed
CT.gov ID
NCT02180074
Collaborator
(none)
137
1
44.2
3.1

Study Details

Study Description

Brief Summary

Cardiovascular disease which includes coronary artery disease and peripheral artery disease remains the leading cause of death among women in the United States. The impact of cardiovascular in women was not recognized by clinicians for a long time. It is now evident that, women suffer the consequences of cardiovascular at rates at least as high as those observed in men but there are still major gaps in our understanding this disease in women. Hydrogen sulfide (H2S), a gaseous mediator plays an important role in the cardiovascular system. Research has demonstrated it's critical role in animal ischemia reperfusion models. Hydrogen sulfide exists in distinct biological pools in blood. Recently, the Kevil lab has pioneered the development of new analytical techniques for accurate measurement of all biological pools of H2S. By measuring these distinct pools of H2S in women with and without cardiovascular disease the investigators hope to further understanding of role of H2S in pathophysiology of cardiovascular disease. This research will help to assess the ability of H2S and its distinct biological pools to potentially be a diagnostic marker or a therapeutic target for cardiovascular disease.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    137 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Measurement of Distinct Biological Pools of Hydrogen Sulfide in Women With Cardiovascular Disease
    Study Start Date :
    Sep 1, 2013
    Actual Primary Completion Date :
    May 7, 2017
    Actual Study Completion Date :
    May 7, 2017

    Arms and Interventions

    Arm Intervention/Treatment
    I

    Women without PAD (ABI >1.0 and <1.4) or CAD, and < 2 risk factors for cardiovascular disease (to serve as healthy controls)

    II

    Women without PAD (ABI>1.0 and <1.4) or CAD and > 2 risk factors for cardiovascular disease

    III

    Women with PAD as defined by ABI <0.9 and a coronary angiogram without any significant coronary artery disease.

    IV

    Women with CAD without PAD, as defined by >50% stenosis by coronary angiography and ABI >1.0 and <1.4.

    V

    Women with both CAD and PAD.

    Outcome Measures

    Primary Outcome Measures

    1. Free Sulfide, Bound Sulfide and Acid Labile Sulfide [1 year]

      Unit of Measure: nMol

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    40 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. Patients presenting to the cardiac catheterization laboratory for coronary or peripheral angiography.

    2. Females,Age>40years

    Exclusion Criteria:
    1. Inability to provide informed consent.

    2. STelevationmyocardialinfarction.

    3. Cardiogenicshock.

    4. ABI >1.4 (indicative of non-compressible vessel needing further evaluation to diagnose PAD), unless documented known PAD. 4. Non-atheroscleroticPAD(e.g.Buerger'sdisease). 5. Enrolment in another clinical trial with use of experimental therapeutic agents.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 LSUHSC Shreveport Louisiana United States 71103

    Sponsors and Collaborators

    • Louisiana State University Health Sciences Center Shreveport

    Investigators

    • Principal Investigator: Christopher Kevil, PhD, LSUHSC Shreveport

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Christopher Kevil, Professor, Louisiana State University Health Sciences Center Shreveport
    ClinicalTrials.gov Identifier:
    NCT02180074
    Other Study ID Numbers:
    • SRKH2SPOOLS
    First Posted:
    Jul 2, 2014
    Last Update Posted:
    Sep 2, 2021
    Last Verified:
    Jun 1, 2014
    Keywords provided by Christopher Kevil, Professor, Louisiana State University Health Sciences Center Shreveport
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 2, 2021